We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Innovative Smartband Predicts Pending Epileptic Seizures

By HospiMedica International staff writers
Posted on 23 Jan 2019
Image: The Empatica Embrace epilepsy smartband (Photo courtesy of Empatica).
Image: The Empatica Embrace epilepsy smartband (Photo courtesy of Empatica).
A novel bracelet device detects motion patterns and physiological signals that may be associated with generalized tonic clonic (GTC) epileptic seizures.

The Empatica (Cambridge, MA, USA) Embrace epilepsy smartband measures a range of electrodermal activity (EDA) data in order to quantify physiological changes that are related to sympathetic nervous system activity. An on-board algorithm continuously processes sensor data and make a decision about whether the data might indicate a GTC seizure. Embrace then sends a message to the smartphone application, which initiates calls and texts to summon a designated caregiver. The wearable biosensor device also captures, stores, and wirelessly transmits EDA data for future analysis.

In a multi-site clinical study, 135 patients diagnosed with epilepsy underwent continuous monitoring with video electroencephalography (EEG), while simultaneously wearing an Empatica device, resulting in 6,530 hours of data recorded over 272 days, including documentation of 40 GTC seizures; the algorithm detected 100% of the seizures clinically labelled by at least two out of three independent epileptologists, who examined the video-EEG data without seeing any data used by Embrace.

“Medical devices face a huge problem: they're usually too bulky and uncomfortable, and people simply don't want to wear them. Empatica took a different path. We wanted to design the world's first medical device that could win a design award, while being used as a lifesaving product,” said Matteo Lai, CEO and co-founder of Empatica. “Patients actually love Embrace and are proud to wear it. We think this has been one of the keys of its success and an interesting lesson for healthcare. Cutting edge technology and good design need to go together.”

A GTC (commonly known as a grand mal seizure) produces bilateral, convulsive, tonic and clonic muscle contractions. They typically start abruptly with either focal or generalized onset, with tonic contractions usually preceding clonic contractions. After these series of contractions, there is an extended post-ictal state where the person is unresponsive and commonly asleep, with loud snoring. Pronounced confusion is usually present upon awakening.

Related Links:
Empatica

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
New
Knee Arthroscopy Holder
Reison 10-353 XL
New
Instrument Cabinet
TRZY-068

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more